Product
Artemether: Lumefantrine
1 clinical trial
1 indication
Indication
MalariaClinical trial
Multicenter, Open-label, Single-arm Study to Evaluate the PK, Safety, Tolerability and Efficacy of a New Artemether:Lumefantrine (2.5 mg:30 mg) Dispersible Tablet in the Treatment of Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum MalariaStatus: Active (not recruiting), Estimated PCD: 2023-06-30